Axitinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Axitinib
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Axitinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 6 USDMF, 5 EU WC, 4 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
6 USDMF
5 EU WC
4 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 6 FDA Orange Book, 22 Europe, 2 Canada, 4 Australia, 2 South Africa, 4 Listed Dossiers

40 FDF Dossiers
6 FDA Orange Book
22 Europe
2 Canada
4 Australia
2 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
2 DKSH
3 Faran Shimi Pharmaceutical
4 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
5 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
9 Microlex e.U
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 12 Direct Compression, 10 Granulation, 9 Lubricants & Glidants, 9 Thickeners and Stabilizers, 7 Coating Systems & Additives, 7 Co-Processed Excipients, 4 Film Formers & Plasticizers, 3 Controlled & Modified Release, 3 Taste Masking, 2 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Parenteral, 1 Emulsifying Agents

37 Fillers, Diluents & Binders
13 Disintegrants & Superdisintegrants
12 Direct Compression
10 Granulation
9 Lubricants & Glidants
9 Thickeners and Stabilizers
7 Coating Systems & Additives
7 Co-Processed Excipients
4 Film Formers & Plasticizers
3 Controlled & Modified Release
3 Taste Masking
2 Coloring Agents
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 Parenteral
1 Emulsifying Agents

DIGITAL CONTENT

75 NEWS #PharmaBuzz

75 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 15 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
15 Finished Drug Prices
10 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

16 US Patents, 8 Health Canada Patents

16 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 453,498 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Pfizer Canada ULC

filter Patent Reset all filters

8 All

01 42383630

02 42682859

filter Product Reset all filters

8 All

01 4AXITINIB

02 4Axitinib

filter Dosage Reset all filters

8 All

01 4TABLET

02 4Tablet

filter Exp Date Reset all filters

8 All

01 42020-06-30

02 42028-03-25

Product Main Page

01

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 1 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

07

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Brand Name : INLYTA

Patent Number : 2682859

Filing Date : 2008-03-25

Strength per Unit : 7 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-25

Date Granted : 2013-10-08

Portfolio PDF

Product Web Link

Digital Content

08

Pfizer Canada ULC

Axitinib

PharmScience R&D

Not Confirmed

Pfizer Canada ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Brand Name : INLYTA

Patent Number : 2383630

Filing Date : 2000-06-30

Strength per Unit : 7 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-06-30

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!